James S. Miser - Concepedia

Author

James S. Miser

National Cancer Institute

Also Known As

Gebhardt, Mark, Grier, Holcombe E., J Miser, J S Miser, James Miser, James S Miser, James S. Miser, Tai-Tong Wong

106

Publications

6.4K

Citations

H-Index

103

Concepts

All Affiliations

National Cancer Institute City Of Hope National Medical Center National Institutes of Health University of Southern California University of Washington

About

James S. Miser is an author at National Cancer Institute specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	2K
2	Health Sciences	9	9	474
3	Public Health	3	3	134
4	Education	1	1	96
5	Social Sciences	1	1	20

James S. Miser

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone Holcombe E. Grier, Mark Krailo, Nancy J. Tarbell, New England Journal of Medicine	2003	1.3K
Chromosome Translocation in Peripheral Neuroepithelioma Jacqueline Whang‐Peng, Timothy J. Triche, Turid Knutsen, New England Journal of Medicine Tumor InnervationCytogeneticsPathologyPeripheral NervesGlioma	1984	400
Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study Linda Granowetter, Richard B. Womer, Meenakshi Devidas, Journal of Clinical Oncology	2009	323
Secondary Leukemia or Myelodysplastic Syndrome After Treatment With Epipodophyllotoxins Malcolm A. Smith, James R. Anderson, Diane C. Arthur, Journal of Clinical Oncology	1999	285
IMMUNE RESPONSE AFTER SPLENECTOMY JohnL. Sullivan, Gerald Schiffman, James S. Miser, The Lancet Clinical ImmunologyImmunologyAutoimmunitySurgeryImmunosuppression	1978	235
Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group Study James S. Miser, Mark Krailo, Nancy J. Tarbell, Journal of Clinical Oncology	2004	207
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group Patrick J. Leavey, Leo Mascarenhas, Neyssa Marina, Pediatric Blood & Cancer	2008	200
Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group Marcio H. Malogolowkin, Cecilia A. Cotton, Daniel M. Green, Pediatric Blood & Cancer	2007	193
The prevalence of pain in a pediatric and young adult cancer population Angela W. Miser, Judith A. Dothage, Robert Wesley, Pain	1987	172
Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology Group Torunn I. Yock, Mark Krailo, Christopher Fryer, Journal of Clinical Oncology	2006	154

Page 1